94 related articles for article (PubMed ID: 7678229)
1. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
Sansom DM; Hall ND
Eur J Immunol; 1993 Jan; 23(1):295-8. PubMed ID: 7678229
[TBL] [Abstract][Full Text] [Related]
2. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions.
Wyss-Coray T; Mauri-Hellweg D; Baumann K; Bettens F; Grunow R; Pichler WJ
Eur J Immunol; 1993 Sep; 23(9):2175-80. PubMed ID: 7690323
[TBL] [Abstract][Full Text] [Related]
3. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
4. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
5. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells.
Norton SD; Zuckerman L; Urdahl KB; Shefner R; Miller J; Jenkins MK
J Immunol; 1992 Sep; 149(5):1556-61. PubMed ID: 1380533
[TBL] [Abstract][Full Text] [Related]
6. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
[TBL] [Abstract][Full Text] [Related]
7. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
8. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
[TBL] [Abstract][Full Text] [Related]
9. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7.
Damle NK; Linsley PS; Ledbetter JA
Eur J Immunol; 1991 May; 21(5):1277-82. PubMed ID: 1645270
[TBL] [Abstract][Full Text] [Related]
10. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
[TBL] [Abstract][Full Text] [Related]
12. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of a novel anti-B7 monoclonal antibody.
de Boer M; Parren P; Dove J; Ossendorp F; van der Horst G; Reeder J
Eur J Immunol; 1992 Dec; 22(12):3071-5. PubMed ID: 1280221
[TBL] [Abstract][Full Text] [Related]
15. Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells.
Lombardi G; Sidhu S; Dodi T; Batchelor R; Lechler R
Eur J Immunol; 1994 Mar; 24(3):523-30. PubMed ID: 7510233
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
17. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.
Nabavi N; Freeman GJ; Gault A; Godfrey D; Nadler LM; Glimcher LH
Nature; 1992 Nov; 360(6401):266-8. PubMed ID: 1279442
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.
Hirokawa M; Kitabayashi A; Kuroki J; Miura AB
Immunology; 1995 Oct; 86(2):155-61. PubMed ID: 7490112
[TBL] [Abstract][Full Text] [Related]
19. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction.
Watts TH; Alaverdi N; Wade WF; Linsley PS
J Immunol; 1993 Mar; 150(6):2192-202. PubMed ID: 7680686
[TBL] [Abstract][Full Text] [Related]
20. MRC OX-2 defines a novel T cell costimulatory pathway.
Borriello F; Lederer J; Scott S; Sharpe AH
J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
